These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 11303380)
1. Fexofenadine hydrochloride--a new anti-histaminic drug. Amichai B; Grunwald MH; Brenner L Isr Med Assoc J; 2001 Mar; 3(3):207-9. PubMed ID: 11303380 [No Abstract] [Full Text] [Related]
2. Fexofenadine: new preparation. Terfenadine, without cardiotoxicity. Prescrire Int; 1999 Feb; 8(39):11-3. PubMed ID: 10557567 [TBL] [Abstract][Full Text] [Related]
3. Safety and efficacy of oral fexofenadine in children with seasonal allergic rhinitis--a pooled analysis of three studies. Meltzer EO; Scheinmann P; Rosado Pinto JE; Bachert C; Hedlin G; Wahn U; Finn AF; Ruuth E Pediatr Allergy Immunol; 2004 Jun; 15(3):253-60. PubMed ID: 15209959 [TBL] [Abstract][Full Text] [Related]
4. Fexofenadine: a review of its use in the management of seasonal allergic rhinitis and chronic idiopathic urticaria. Simpson K; Jarvis B Drugs; 2000 Feb; 59(2):301-21. PubMed ID: 10730552 [TBL] [Abstract][Full Text] [Related]
6. Comparison of montelukast and fexofenadine for chronic idiopathic urticaria. Nettis E; Dambra P; D'Oronzio L; Loria MP; Ferrannini A; Tursi A Arch Dermatol; 2001 Jan; 137(1):99-100. PubMed ID: 11176678 [No Abstract] [Full Text] [Related]
7. The utility of mixed-effects covariate analysis in rapid selection of doses in pediatric subjects: a case study with fexofenadine hydrochloride. Krishna R; Krishnaswami S; Kittner B; Sankoh AJ; Jensen BK Biopharm Drug Dispos; 2004 Dec; 25(9):373-87. PubMed ID: 15517550 [TBL] [Abstract][Full Text] [Related]
8. [Further development of terfenadine]. Paul E Hautarzt; 1997 Aug; 48(8 Suppl):7. PubMed ID: 9378647 [No Abstract] [Full Text] [Related]
9. The clinical efficacy of H1 antagonists in urticaria and rhinitis. Rihoux JP; Donnelly F; Burtin B J Allergy Clin Immunol; 1998 Aug; 102(2):333-4. PubMed ID: 9723686 [No Abstract] [Full Text] [Related]
10. [Effect of fexofenadine--selective antagonist of histamine receptor (H1) on histamine-induced bronchoconstriction]. Grzelewska-Rzymowska I; KroczyĆska-Bednarek J; Pietrzkowicz M Pol Merkur Lekarski; 2003 Jan; 14(79):43-6. PubMed ID: 12712828 [TBL] [Abstract][Full Text] [Related]
11. Mizolastine and fexofenadine modulate cytokine pattern after nasal allergen challenge. Ciprandi G; Cirillo I; Vizzaccaro A Eur Ann Allergy Clin Immunol; 2004 Apr; 36(4):146-50. PubMed ID: 15180356 [TBL] [Abstract][Full Text] [Related]
12. [Multiple prevention. On the way to an ideal antihistamine?]. MMW Fortschr Med; 2000 Jan; 142(1-2):48-9. PubMed ID: 11291160 [No Abstract] [Full Text] [Related]
13. [Hay fever and asthma. Many of your patients have both]. MMW Fortschr Med; 2002 Apr; 144(17):49. PubMed ID: 12048855 [No Abstract] [Full Text] [Related]
14. Studies into the possible central effects of the H-1 receptor antagonist, fexofenadine. Stone BM; Turner C; Mills SL; Nicholson AN Int Arch Allergy Immunol; 1999; 118(2-4):338. PubMed ID: 10224436 [No Abstract] [Full Text] [Related]
15. Newer antihistamines. Med Lett Drugs Ther; 2001 Apr; 43(1103):35. PubMed ID: 11331439 [No Abstract] [Full Text] [Related]
16. [The efficacy of the Zirtek (cetirizine) preparation in chronic recurrent urticaria and seasonal allergic rhinitis]. Androsov VN; Belostotskaia OI; Il'ina NI Ter Arkh; 1994; 66(11):68-72. PubMed ID: 7900025 [TBL] [Abstract][Full Text] [Related]
17. The changing face of antihistamines and cardiac adverse drug reactions: a clinical perspective. Shaikh WA J Indian Med Assoc; 2000 Jul; 98(7):397-9. PubMed ID: 11143865 [TBL] [Abstract][Full Text] [Related]
18. Effect of 60 mg twice-daily fexofenadine HCl on quality of life, work and classroom productivity, and regular activity in patients with chronic idiopathic urticaria. Thompson AK; Finn AF; Schoenwetter WF J Am Acad Dermatol; 2000 Jul; 43(1 Pt 1):24-30. PubMed ID: 10863219 [TBL] [Abstract][Full Text] [Related]